Publications | PubMed=7622289; DOI=10.1002/ijc.2910620208 Itte De Waard-Siebinga, Derk-Jan R. Blom, Marieke Griffioen, Peter I. Schrier, Ed Hoogendoorn, Geoffrey C. Beverstock, Erik H.J. Danen, Martine Johanna Jager; Establishment and characterization of an uveal-melanoma cell line. Int. J. Cancer 62:155-161(1995) PubMed=15714118; DOI=10.1097/00008390-200502000-00006 Rosario Lopez-Velasco, Antonio Morilla-Grasa, Maria Antonia Saornil-Alvarez, Jose L. Ordonez, Gonzalo Blanco, Guillermo Rabano, Nieves Fernandez, Ana Almaraz; Efficacy of five human melanocytic cell lines in experimental rabbit choroidal melanoma. Melanoma Res. 15:29-37(2005) PubMed=16772116; DOI=10.1016/j.cancergencyto.2005.11.016 Jason S. White, Robert L. Becker, Ian W. McLean, Alison E. Director-Myska, Joginder Nath; Molecular cytogenetic evaluation of 10 uveal melanoma cell lines. Cancer Genet. Cytogenet. 168:11-21(2006) PubMed=17487557; DOI=10.1007/s10585-007-9072-z Jean-Claude Marshall, Andre Nantel, Paula Blanco, Josee Ash, Stephanie R. Cruess, Miguel Noel Burnier Jr.; Transcriptional profiling of human uveal melanoma from cell lines to intraocular tumors to metastasis. Clin. Exp. Metastasis 24:353-362(2007) PubMed=19340423; DOI=10.1007/s00262-009-0701-z; PMCID=PMC11030131 Rosa Mendez, Natalia Aptsiauri, Ana Del Campo, Isabel Maleno, Teresa Cabrera, Francisco Ruiz-Cabello Osuna, Federico Garrido, Angel Garcia-Lora; HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank. Cancer Immunol. Immunother. 58:1507-1515(2009) PubMed=22236444; DOI=10.1111/j.1755-148X.2012.00971.x; PMCID=PMC3288394 Klaus Georg Griewank, Xiao-Xing Yu, Jahan S. Khalili, Mustafa Mert Sozen, Katherine Stemke-Hale, Chantale Bernatchez, Seth Wardell, Boris C. Bastian, Scott E. Woodman; Genetic and molecular characterization of uveal melanoma cell lines. Pigment Cell Melanoma Res. 25:182-187(2012) PubMed=22383533; DOI=10.1158/1535-7163.MCT-11-0676 Ken Dutton-Regester, Darryl Irwin, Priscilla Hunt, Lauren G. Aoude, Varsha Tembe, Gulietta M. Pupo, Cathy Lanagan, Candace D. Carter, Linda O'Connor, Michael O'Rourke, Richard Anthony Scolyer ...Show all 15 authors... , Graham J. Mann, Christopher W. Schmidt, Adrian Herington, Nicholas K. Hayward; Show fewer authors A high-throughput panel for identifying clinically relevant mutation profiles in melanoma. Mol. Cancer Ther. 11:888-897(2012) PubMed=23849826; DOI=10.1016/j.ejca.2013.06.011 Adriana Amaro, Valentina Mirisola, Giovanna Angelini, Alessandra Musso, Francesca Isabella Tosetti, Alessia Isabella Esposito, Patrizia Perri, Francesco Baldo Lanza, Francesca Nasciuti, Carlo Mosci, Roberto Puzone ...Show all 15 authors... , Sandra Salvi, Mauro Truini, Alessandro Poggi, Ulrich Pfeffer; Show fewer authors Evidence of epidermal growth factor receptor expression in uveal melanoma: inhibition of epidermal growth factor-mediated signalling by gefitinib and cetuximab triggered antibody-dependent cellular cytotoxicity. Eur. J. Cancer 49:3353-3365(2013) PubMed=23851445; DOI=10.1158/1541-7786.MCR-13-0006 Christina Dahl, Claus Christensen, Goran Jonsson, Anders Lorentzen, Mette Louise Skjodt, Ake Borg, Graham Pawelec, Per Guldberg; Mutual exclusivity analysis of genetic and epigenetic drivers in melanoma identifies a link between p14 ARF and RARbeta signaling. Mol. Cancer Res. 11:1166-1178(2013) PubMed=24994677; DOI=10.1016/j.molonc.2014.06.004; PMCID=PMC5528590 Nabil Amirouchene-Angelozzi, Fariba Nemati, David Gentien, Andre Nicolas, Amaury Dumont, Guillaume Carita, Jacques Camonis, Laurence Desjardins, Nathalie Cassoux, Sophie Piperno-Neumann, Pascale Mariani ...Show all 14 authors... , Xavier Sastre-Garau, Didier Decaudin, Sergio Roman-Roman; Show fewer authors Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target. Mol. Oncol. 8:1508-1520(2014) PubMed=28018010; PMCID=PMC5161001 Martine Johanna Jager, Jose Antonio Bermudez Magner, Bruce R. Ksander, Sander R. Dubovy; Uveal melanoma cell lines: where do they come from? (an American Ophthalmological Society thesis). Trans. Am. Ophthalmol. Soc. 114:T5-T5(2016) PubMed=32430489; DOI=10.1158/1535-7163.MCT-19-1016; PMCID=PMC7415561 Jessica L.F. Teh, Timothy J. Purwin, Anna Han, Vivian Chua, Prem Patel, Usman Baqai, Connie Liao, Nelisa Bechtel, Takami Sato, Michael A. Davies, Julio A. Aguirre-Ghiso, Andrew E. Aplin; Metabolic adaptations to MEK and CDK4/6 cotargeting in uveal melanoma. Mol. Cancer Ther. 19:1719-1726(2020) PubMed=36164296; DOI=10.1016/j.dib.2022.108592; PMCID=PMC9508510 Xi-Feng Fei, Xiang-Tong Xie, Xiao-Yan Ji, Hai-Yan Tian, Fei Sun, Dong-Yi Jiang, Zhi-Min Wang, Qiang Huang; Quantitative proteomic dataset of whole protein in three melanoma samples of 92.1, 92.1-A and 92.1-B. Data Brief 45:108592.1-108592.7(2022) PubMed=38601020; PMCID=PMC11006005 Coralie Doudnikoff, Delphine Leclerc, Gaelle Angenard, David Gilot, Cedric Coulouarn, Frederic Mouriaux; Uveal melanoma cell lines Mel270 and 92.1 exhibit a mesenchymal phenotype and sensitivity to the cytostatic effects of transforming growth factor beta in vitro. Mol. Vis. 30:160-166(2024) PubMed=39042403; DOI=10.1167/iovs.65.8.37; PMCID=PMC11268447 Maria Chiara Gelmi, Arnoud H. de Ru, Peter A. van Veelen, Rayman T.N. Tjokrodirijo, Marc-Henri Stern, Alexandre Houy, Robert M. Verdijk, T.H. Khanh Vu, Bruce R. Ksander, Jolanda Vaarwater, Emine Kilic ...Show all 13 authors... , Erwin Brosens, Martine Johanna Jager; Show fewer authors Protein and mRNA expression in uveal melanoma cell lines are related to GNA and BAP1 mutation status. Invest. Ophthalmol. Vis. Sci. 65:37-37(2024) |